|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Cash and cash equivalents | |||||
| Cash and due from banks | |||||
| Interest-bearing accounts with other banks | |||||
| Federal funds sold | |||||
| Total cash and cash equivalents | |||||
| Investments | |||||
| Securities available-for-sale, at fair value | |||||
| Non-marketable equity securities | |||||
| Total investments | |||||
| Loans held for sale | |||||
| Loans held for investment | |||||
| Allowance for credit losses on loans | |||||
| Loans held for investment, net | |||||
| Bank-owned life insurance | |||||
| Premises, furniture and equipment, net | |||||
| Deferred tax asset | |||||
| Goodwill | |||||
| Intangible assets | |||||
| Other assets | |||||
| Total assets | |||||
| Liabilities | |||||
| Deposits | |||||
| Non-interest bearing transaction accounts | |||||
| Interest-bearing transaction accounts | |||||
| Savings and money market | |||||
| Time deposits | |||||
| Total deposits | |||||
| Other borrowings | |||||
| Other liabilities | |||||
| Total liabilities | |||||
| Shareholders' Equity | |||||
| Preferred stock, $1.00 par value, 10,000,000 shares authorized, no shares issued or outstanding | |||||
| Common stock | |||||
| Voting Common Stock | |||||
| Non-voting Common Stock | |||||
| Capital surplus | |||||
| Retained earnings | |||||
| Accumulated other comprehensive loss | |||||
| Total shareholders' equity | |||||
| Total liabilities and shareholders' equity |
Loading...
